RegeneGene (688217.SH) announced on September 27th that it has received a notice from shareholder Zhejiang Da Health regarding the expiration of the period for the shareholding reduction plan of Shanghai RegeneGene Technology Co., Ltd., as of September 27, 2024, Zhejiang Da Health has reduced its holdings of the company's shares by 557,558 shares through centralized bidding trading, accounting for 0.9982% of the total share capital. The time range for this shareholding reduction plan has expired.
睿昂基因(688217.SH)：浙江大健康累计减持0.9982%股份
Ruiang Gene (688217.SH): Zhejiang Health has cumulatively reduced its shareholding by 0.9982%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated